Carbapenem is one of the mainstay of treatment for severe hospital infection caused by KP, while, the drastic increase in the prevalence of carbapenem-resistant KP (CRKP) have caused high morbidity and mortality rates, and leading to a global epidemic in hospitals (Chapelle et al., 2021). The gene discussed is NPPA; the disease is infection.